Immune memory against SARS-CoV-2 can be utilized in the fight against tumors.
Scientists from Celloram Inc., University Hospitals, and Case Western Reserve University have developed a new cancer vaccine platform that could redefine the future of cancer immunotherapy. This discovery is being hailed as a significant breakthrough in the field of medicine.
This innovative approach transforms the synchronized mass immune memory generated through SARS-CoV-2 infection and vaccination into a powerful ally against cancer. Researchers state that the immune response created against the coronavirus can now also be applied in the fight against oncological diseases.
This innovative dendritic cell vaccine platform named PROTEXI was presented in research published in Nature Communications journal. This new technology has the potential to offer more effective and targeted methods in cancer treatment.
More detailed information has been published in Technology Networks.